Home Drug pricing

Keyword: Drug pricing

11 results found

A British Columbia labour arbitration decision is providing insight on how a block level implementation of a benefits provider’s drug cost-control program violated a collective agreement in a unionized workplace. The Douglas College Faculty Association grieved the implementation of Manulife’s DrugWatch program contravened their collective agreement, which ensured “there will be no change to the […]

Copyright_ilixe48_123RF

An announcement regarding long-awaited amendments to the Patented Medicines Review Board regulations was the most-read story on BenefitsCanada.com over the last week. Here are the five most popular news stories of the week: 1. PMPRB drug pricing regulations officially coming into effect this July 2. Key stakeholders highlighting value of private payer health care amid plans for […]

  • By: Staff
  • April 22, 2022 April 21, 2022
  • 09:00

After multiple delays, the amendments to the Patented Medicines Review Board regulations will finally come into force on July 1, 2022. Last week, Health Minister Jean-Yves Duclos announced the federal government will proceed with the amendments to provide the PMPRB with new tools to protect Canadians from excessive prices for patented medicines. “This will improve access for […]

  • By: Staff
  • April 19, 2022 April 18, 2022
  • 09:00

This month marks the second anniversary of the beginning of the coronavirus pandemic, a 24-month span that has had profound effects on the health of benefits plan members and the status and structure of their plans. For drug plans in particular, several trends have come to light — or have accelerated — during the course […]

How the City of Toronto is continuing to support employee mental health in these uncertain times took the top spot over the past week on BenefitsCanada.com. Here are the five most popular news stories of the week: 1. How the City of Toronto is supporting employee mental health in 2022 and beyond 2. Why CPP premiums are getting […]

  • By: Staff
  • January 7, 2022 January 7, 2022
  • 09:00

Employers are likely to see the expansion and tweaking of current health and well-being trends next year, according to the Business Group on Health. Virtual health care that integrates with in-person offerings and the continued expansion of mental-health and well-being services are among six trends that will underscore a “collective urgency” for employers and their […]

  • By: Staff
  • December 23, 2021 December 10, 2021
  • 09:00

Critics of a major drug price overhaul hope a fresh federal cabinet will put a temporary stop to the new regulations set to take effect in January. The Patented Medicine Prices Review Board is set to change the way it sets a price cap on medicines in Canada in an effort to lower excessively expensive drug costs. […]

As innovative medicines become more widely covered in workplace drug plans, employers are tasked with finding new ways to control costs while ensuring members receive the best value. “Obviously, this is good because such offers provide more treatments for employees and their families that can help get them back to the workplace sooner rather than […]

Copyright_Wavebreak Media Ltd_123RF

Discussion around implementing a national universal pharmacare strategy is growing louder ahead of next month’s federal election. In its 2019 budget, the federal government said it would work with partners to move forward on a national pharmacare program, including the creation of a new national drug agency and formulary, as well as a national strategy for […]

Copyright_ spirer_123RF

The Canadian Life and Health Insurance Association is calling on the federal government to permit standalone variable payment life annuities to pool participants from all registered retirement plans. In its 2022 federal budget submission, the CLHIA said VPLAs, as enacted, will only be available to members of very large defined contribution pension plans, excluding Canadians […]

  • By: Staff
  • August 9, 2021 August 9, 2021
  • 15:00